NCI-2024-03914

Phase 1 Trial of the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Clinical Activity of RP-1664 in Participants with Advanced Solid Tumors

This Phase 1 clinical trial investigates RP-1664 in participants with advanced solid tumors. The study focuses on assessing the safety, pharmacokinetics (how the drug moves in the body), pharmacodynamics (how the drug affects the body), and initial clinical activity of RP-1664. The goal is to understand how well the drug works and its safety profile in treating advanced solid tumors.

For more information about the trial, click the link below:

https://clinicaltrials.gov/ct2/show/NCT06232408

Clinical Trial Site: Columbia

To see all available clinical trials click here.